133 related articles for article (PubMed ID: 25974079)
1. Synthesis of daumone derivatives and their antiangiogenic activities on chorioallantoic membrane.
Ricci J; Min D; Oh M; Lim H; Chung WY; Park KK; Jung M
Med Chem; 2015; 11(8):747-52. PubMed ID: 25974079
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
Jung M; Tak J; Chung WY; Park KK
Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
[TBL] [Abstract][Full Text] [Related]
3. Chemical structure and biological activity of the Caenorhabditis elegans dauer-inducing pheromone.
Jeong PY; Jung M; Yim YH; Kim H; Park M; Hong E; Lee W; Kim YH; Kim K; Paik YK
Nature; 2005 Feb; 433(7025):541-5. PubMed ID: 15690045
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
An ZY; Yan YY; Peng D; Ou TM; Tan JH; Huang SL; An LK; Gu LQ; Huang ZS
Eur J Med Chem; 2010 Sep; 45(9):3895-903. PubMed ID: 20554355
[TBL] [Abstract][Full Text] [Related]
5. Pyridoxine-derived bicyclic amido-, ureido-, and carbamato-pyridinols: synthesis and antiangiogenic activities.
Lee H; Kim DG; Banskota S; Lee YK; Nam TG; Kim JA; Jeong BS
Org Biomol Chem; 2014 Nov; 12(43):8702-10. PubMed ID: 25255328
[TBL] [Abstract][Full Text] [Related]
6. Concise synthesis and antiangiogenic activity of artemisinin-glycolipid hybrids on chorioallantoic membranes.
Ricci J; Park J; Chung WY; Park KK; Jung M
Bioorg Med Chem Lett; 2010 Nov; 20(22):6858-60. PubMed ID: 20855209
[TBL] [Abstract][Full Text] [Related]
7. Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
da Costa PM; da Costa MP; Carvalho AA; Cavalcanti SM; de Oliveira Cardoso MV; de Oliveira Filho GB; de Araújo Viana D; Fechine-Jamacaru FV; Leite AC; de Moraes MO; Pessoa C; Ferreira PM
Chem Biol Interact; 2015 Sep; 239():174-83. PubMed ID: 26134001
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols.
Lee H; Banskota S; Kim DG; Been JH; Jin YJ; Gautam J; Jang H; Nam TG; Kim JA; Jeong BS
Bioorg Med Chem Lett; 2014 Jul; 24(14):3131-6. PubMed ID: 24894557
[TBL] [Abstract][Full Text] [Related]
9. Triterpenes from leaves of Cheiloclinium cognatum and their in vivo antiangiogenic activity.
Pereira RCG; Soares DCF; Oliveira DCP; de Sousa GF; Vieira-Filho SA; Mercadante-Simões MO; Lula I; Silva-Cunha A; Duarte LP
Magn Reson Chem; 2018 May; 56(5):360-366. PubMed ID: 29388257
[No Abstract] [Full Text] [Related]
10. Synthesis and anti-angiogenetic activity evaluation of N-(3-aryl acryloyl)aminosaccharide derivatives.
Liu K; Yao S; Lou Y; Xu Y
Carbohydr Res; 2013 Nov; 381():83-92. PubMed ID: 24077357
[TBL] [Abstract][Full Text] [Related]
11. Metabolite induction of Caenorhabditis elegans dauer larvae arises via transport in the pharynx.
Baiga TJ; Guo H; Xing Y; O'Doherty GA; Dillin A; Austin MB; Noel JP; La Clair JJ
ACS Chem Biol; 2008 May; 3(5):294-304. PubMed ID: 18376812
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities.
Yu G; Li Z; Tang L; Xiong Q
Molecules; 2014 Jun; 19(7):8916-32. PubMed ID: 24972275
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel N
Guo L; Ma Q; Chen W; Fan W; Zhang J; Dai B
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):375-387. PubMed ID: 30734606
[TBL] [Abstract][Full Text] [Related]
14. TX-2152: a conformationally rigid and electron-rich diyne analogue of FTY720 with in vivo antiangiogenic activity.
Nakayama S; Uto Y; Tanimoto K; Okuno Y; Sasaki Y; Nagasawa H; Nakata E; Arai K; Momose K; Fujita T; Hashimoto T; Okamoto Y; Asakawa Y; Goto S; Hori H
Bioorg Med Chem; 2008 Aug; 16(16):7705-14. PubMed ID: 18678496
[TBL] [Abstract][Full Text] [Related]
15. Quinazoline clubbed 1,3,5-triazine derivatives as VEGFR2 kinase inhibitors: design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity.
Pathak P; Shukla PK; Kumar V; Kumar A; Verma A
Inflammopharmacology; 2018 Dec; 26(6):1441-1453. PubMed ID: 29663100
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antiangiogenic effects of a series of potent novel fumagillin analogues.
Lee HW; Cho CS; Kang SK; Yoo YS; Shin JS; Ahn SK
Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):1024-9. PubMed ID: 17603194
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of Indole-2-carbohydrazide Derivatives as Anticancer Agents with Anti-angiogenic and Antiproliferative Activities.
Zhang J; Liu T; Chen M; Liu F; Liu X; Zhang J; Lin J; Jin Y
ChemMedChem; 2018 Jun; 13(12):1181-1192. PubMed ID: 29637713
[TBL] [Abstract][Full Text] [Related]
18. Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.
Bridoux A; Cui H; Dyskin E; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2009 Jun; 19(12):3259-63. PubMed ID: 19427201
[TBL] [Abstract][Full Text] [Related]
19. Novel pyrazole derivatives: synthesis and evaluation of anti-angiogenic activity.
Christodoulou MS; Liekens S; Kasiotis KM; Haroutounian SA
Bioorg Med Chem; 2010 Jun; 18(12):4338-50. PubMed ID: 20493716
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel 2-methoxyestradiol analogs as dual selective estrogen receptor modulators (SERMs) and antiangiogenic agents.
Lao K; Wang Y; Chen M; Zhang J; You Q; Xiang H
Eur J Med Chem; 2017 Oct; 139():390-400. PubMed ID: 28810190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
